Last updated at 23 Jan 2025 11:06 AM
Director
DIN: 06513997
Sreedevi Patibandla is currently associated with 2 companies in various capacities such as Whole-time director and Designated Partner. They serve as a Director at RAGHAVENDHRA PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06513997.Sreedevi Patibandla has previously been associated with 1 company in roles such as Director.Sreedevi Patibandla is currently involved in 2 different roles. Their most recent position is with SKS LIFE SCIENCES LLP as a Designated Partner. The first company Sreedevi Patibandla was appointed to was RAGHAVENDHRA PHARMA PRIVATE LIMITED. Sreedevi Patibandla is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sreedevi Patibandla is currently associated with 2 companies in various capacities such as Whole-time director and Designated Partner. They serve as a Director at RAGHAVENDHRA PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06513997.Sreedevi Patibandla has previously been associated with 1 company in roles such as Director.Sreedevi Patibandla is currently involved in 2 different roles. Their most recent position is with SKS LIFE SCIENCES LLP as a Designated Partner. The first company Sreedevi Patibandla was appointed to was RAGHAVENDHRA PHARMA PRIVATE LIMITED. Sreedevi Patibandla is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
2y 7m 1y 4m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| RAGHAVENDHRA PHARMA PRIVATE LIMITED | Whole-time director | 21-Aug-2015 |